Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized anxiety disorder: A comorbid disease.

David Nutt1, Spilos Argyropoulos, Sean Hood

  • 1Psychopharmacology Unit, University of Bristol, Bristol, United Kingdom. david.j.nutt@bristol.ac.uk

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|June 2, 2006
PubMed
Summary

Generalized anxiety disorder (GAD) often co-occurs with other conditions, leading to greater impairment. New tools like the GADI scale can aid in detecting and monitoring GAD, improving patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Aboriginal Mental Health Journeys Through Psychiatric Care Systems.

JAMA network open·2026
Same author

The goal of specificity in psychotropic drug development: A lesson from Sisyphus?

Journal of psychopharmacology (Oxford, England)·2026
Same author

Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS).

Archives of suicide research : official journal of the International Academy for Suicide Research·2026
Same author

Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study - RETRACTION.

The British journal of psychiatry : the journal of mental science·2026
Same author

Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Evaluation of the impact of low activity imaging in [<sup>11</sup>C]-(+)-PHNO and [<sup>11</sup>C]UCB-J PET-MR scans.

EJNMMI physics·2026

Area of Science:

  • Psychiatry
  • Neuroscience

Background:

  • Generalized anxiety disorder (GAD) frequently presents with comorbid conditions like depression and somatic complaints.
  • Comorbid GAD exacerbates psychologic and social impairment, leading to poorer outcomes and increased treatment needs.

Purpose of the Study:

  • To highlight the challenges in treating comorbid GAD.
  • To introduce the GADI, a self-rating scale for GAD detection and monitoring.
  • To emphasize the need for treatments addressing both GAD and comorbid conditions.

Main Methods:

  • Review of clinical data on comorbid GAD.
  • Introduction of the GADI self-rating scale.
  • Discussion of neurobiologic factors in anxiety (GABA, serotonin).

Main Results:

Related Experiment Videos

  • Comorbid GAD leads to significantly worse outcomes compared to GAD alone.
  • The GADI scale shows potential as a tool for GAD assessment.
  • Understanding neurobiology informs pharmacologic treatment choices.

Conclusions:

  • Effective GAD management requires addressing comorbid conditions.
  • The GADI scale may assist clinicians in GAD detection and monitoring.
  • Optimized diagnosis and treatment can improve patient quality of life and recovery prognosis.